Recent News

• 06.10.2026 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 06.10.2026 - Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
• 06.10.2026 - Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
• 06.02.2026 - Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
• 06.02.2026 - Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
• 05.21.2026 - Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
• 05.21.2026 - Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
• 03.24.2026 - Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
• 03.24.2026 - Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Recent Filings

• 06.04.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 06.04.2026 - 8-K Current report
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.21.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.21.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.21.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.21.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2026 - 4 Statement of changes in beneficial ownership of securities